Earnings Show Double-Digit Growth, Yet Nuclear Beneficiary Stocks Plunge 6% in a Day

Mirion Technologies (NYSE: MIR) closed at $16.96 on the New York Stock Exchange today, down 5.78%. Its market capitalization fell to approximately $4.15 billion—about KRW 5.6 trillion—erasing roughly $227 million (around KRW 300 billion) in a single trading day.

In its Q1 2026 results announced at the end of April, the company reported revenue of $257.6 million, a 27.5% year-over-year increase, but posted a GAAP net loss of $3.4 million. Adjusted earnings per share slightly missed analysts’ forecasts, highlighting lingering profitability challenges. At the same time, management reaffirmed full-year revenue guidance of about $1.1 billion and emphasized robust demand in the nuclear power and medical sectors. Nevertheless, valuation concerns and earnings volatility appear to be weighing on the stock in the near term.

Mirion Technologies provides radiation detection, measurement and monitoring solutions to nuclear power plants, healthcare providers, defense agencies and research institutions. The company has been regarded as a structural growth play amid expanding nuclear investments and rising demand for radiation-based medical services. Through acquisitions such as Paragon and Certrec, Mirion is broadening its footprint in nuclear plant equipment upgrades and regulatory compliance, while accelerating digital transformation and AI-powered solutions following the appointment of a Chief AI & Digital Officer.